What are vaginal lumps?

Vaginal lumps are palpable or visible bumps that occur in or around the vagina. They may arise from a wide range of conditions — benign cysts and skin lesions, infectious processes, inflammatory disorders, or, more rarely, premalignant or malignant growths. Because the differential diagnosis is broad and some causes require timely treatment, evaluation by a clinician — usually a gynecologist or primary care clinician experienced in women's health — is recommended whenever a new lump is discovered. (ACOG, Mayo Clinic)

This article reviews common causes of vaginal and vulvar lumps, how they typically present, how clinicians evaluate them, treatment options, when to seek urgent care, and prevention and follow-up considerations. Information is framed as medical education and references authoritative sources (ACOG, NIH/MedlinePlus, Mayo Clinic, Cleveland Clinic).

Anatomy and terminology

  • "Vaginal" strictly refers to the internal muscular canal between the cervix and the vulva. However, in clinical practice people often use "vaginal area" to mean the vulva (external genital structures) plus the vestibule. Many palpable lumps occur in the vulva, labia majora/minora, or vestibule rather than deep inside the vagina.
  • Key structures relevant to lumps:
  • Bartholin glands: located at the posterior introitus (near 5 and 7 o’clock positions) and can form cysts or abscesses.
  • Skene glands (paraurethral glands): near the urethral opening; may develop cysts.
  • Sweat and sebaceous glands in the vulvar skin.
  • Vaginal wall and submucosa: where Gartner duct cysts and mucous cysts can form.
  • Lymphatic and subcutaneous tissue: sites of lipomas, fibromas, or enlarged lymph nodes.

Understanding the precise anatomic location guides likely causes and management. (ACOG, NIH/MedlinePlus)

Common causes of vaginal and vulvar lumps

Below are common and less common causes grouped by category.

Cysts and glandular lesions

  • Bartholin gland cyst and abscess: One of the most common vulvar masses in reproductive-age individuals. When duct drainage is blocked, mucus collects and produces a painless or mildly uncomfortable cyst; secondary infection can lead to a painful abscess. Small asymptomatic cysts may be observed; symptomatic cysts/abscesses often require drainage or surgical management. (ACOG, Mayo Clinic)
  • Gartner duct cyst: A remnant of the mesonephric (Wolffian) duct that can present as a painless submucosal cyst along the lateral or anterior vaginal wall. Often incidentally found but may cause pressure or dyspareunia if large. (NIH/MedlinePlus)
  • Skene gland (paraurethral) cyst: Located adjacent to the urethra; can cause a palpable anterior vaginal wall mass and sometimes urinary symptoms (dysuria, frequency) if large or infected. (Mayo Clinic, NIH)
  • Epidermal inclusion cysts / sebaceous cysts: Arise from hair follicles or sebaceous glands in vulvar skin. Typically small, round, mobile, and slow-growing. They can become inflamed or infected. (Cleveland Clinic)

Benign soft-tissue masses

  • Lipoma: Benign tumor of adipose tissue; soft, mobile, usually painless.
  • Fibroma: Fibrous connective tissue tumor; firm and well-circumscribed.
  • Hemangioma or vascular malformations: Rare but possible, may blanch with pressure.

Infectious lesions

  • Genital herpes simplex virus (HSV): Causes grouped vesicles that break down into small shallow ulcers that can feel like bumps or sores. Often painful, associated with itching, burning, or dysuria. Systemic antiviral therapy shortens outbreaks and reduces viral shedding. (NIH/MedlinePlus, Mayo Clinic)
  • Condyloma acuminata (genital warts, HPV): Caused by human papillomavirus (HPV), present as fleshy papules or cauliflower-like growths on vulva, perineum, or vaginal walls. May be flat, raised, or clustered. Treatments include patient-applied and clinician-administered therapies. (Mayo Clinic, CDC)
  • Molluscum contagiosum: Viral infection causing small, firm, umbilicated papules. More common in children but may occur in adults. Often resolve spontaneously but can be removed if symptomatic. (NIH/MedlinePlus)
  • Abscess or infected sweat gland: Localized collection of pus from secondary infection; typically painful, red, and tender. (Cleveland Clinic)
  • Hidradenitis suppurativa: Chronic inflammatory disease affecting apocrine gland–bearing areas, including the groin and vulva, with recurrent painful nodules and abscesses that can form sinus tracts and scarring. Management can be medical and surgical. (Cleveland Clinic)

Neoplasms (premalignant and malignant)

  • Vulvar cancer: May present as a persistent lump, ulcer, or area of thickened skin, often accompanied by itching or bleeding. Risk factors include chronic dermatoses (e.g., lichen sclerosus) and high-risk HPV infection. A biopsy is necessary for diagnosis. (ACOG, NIH)
  • Vaginal cancer: Rare; may present as a mass, bleeding, or discharge. Clear cell adenocarcinoma of the vagina has been associated with in utero exposure to diethylstilbestrol (DES). Biopsy confirms diagnosis. (ACOG, NIH)
  • Secondary tumors / metastases: Less common but possible; history of a prior malignancy raises suspicion.

Other causes

  • Enlarged lymph nodes (inguinal lymphadenopathy) can present as nodules near the labia.
  • Traumatic inclusion cysts or hematomas after injury or delivery.
  • Dermatoses such as lichen planus or epidermal hyperplasia that produce focal thickening.

Typical symptoms and clinical features

The clinical presentation depends on the cause, size, location, and whether infection is present.

Common symptom patterns:

  • Painful vs painless: Infected cysts, abscesses, HSV lesions, and hidradenitis tend to be painful. Benign cysts, Gartner duct cysts, and lipomas are often painless unless they enlarge or become infected.
  • Visible vs palpable only: Some lesions are visible externally (warts, molluscum, Bartholin cyst). Deeper vaginal wall masses (Gartner cysts) may be palpable on bimanual exam but not visible externally.
  • Associated symptoms: Itching, burning, malodorous discharge, urinary symptoms (if periurethral), bleeding, or systemic signs (fever) suggest infection or a more aggressive process.

Red flags that require prompt evaluation:

  • Rapidly enlarging mass
  • Persistent or recurrent lumps
  • Unexplained bleeding or ulceration
  • Significant pain or fever
  • Systemic symptoms or weight loss
  • New lump in someone older than 40 years (higher risk of malignancy) (ACOG, Mayo Clinic)

Evaluation and diagnosis

A careful history and focused examination are central.

History:

  • Onset, duration, and rate of growth
  • Pain, discharge, bleeding, itching, urinary symptoms
  • Recent trauma, sexual activity, or new sexual partners
  • History of sexually transmitted infections (STIs) or prior similar lesions
  • Menstrual and obstetric history, contraception
  • Immunocompromise (e.g., HIV), smoking, or DES exposure
  • Prior treatments and response

Physical examination:

  • Inspect the vulva with good lighting; note size, color, surface (ulcerated, smooth, crusted), and whether the lesion is fixed or mobile.
  • Speculum examination to inspect the vaginal walls and cervix when appropriate.
  • Bimanual palpation to assess deeper masses and to evaluate adjacent organs.
  • Gentle palpation may reveal fluctuant (fluid-filled) vs firm characteristics.
  • Lymph node examination of the groin.

Ancillary testing:

  • Culture or nucleic acid amplification tests (NAAT) if infectious STI is suspected (e.g., HSV PCR, HPV testing of cervix does not reliably diagnose vulvar warts).
  • Ultrasonography: Useful for characterizing cystic vs solid masses, localizing Gartner duct cysts or Bartholin gland lesions. Transperineal or transvaginal ultrasound may be used. (Mayo Clinic)
  • MRI: Helpful for complex or deep lesions, suspected invasive disease, or preoperative planning.
  • Biopsy: Any suspicious, persistent, recurrent, or ulcerated lesion should be biopsied. Excisional biopsy or punch biopsy under local anesthesia allows histologic diagnosis and rules out malignancy. (ACOG)

Avoid self-drainage or "squeezing" lesions at home; that increases risk of secondary infection and complicates later evaluation.

Treatment options

Management depends on the diagnosis, symptoms, lesion size, infection status, and patient preferences.

Cysts and Bartholin gland disease

  • Asymptomatic small Bartholin cysts: Observation and pelvic hygiene; many resolve or remain stable.
  • Symptomatic Bartholin cyst or abscess:
  • Initial approaches: Sitz baths, analgesia, and sometimes antibiotics if cellulitis/abscess suspected.
  • Office-based drainage: Incision with placement of a Word catheter (a small balloon catheter) to allow drainage and maintain a patent tract for several weeks. This is commonly used to preserve gland function in reproductive-age individuals. (ACOG)
  • Marsupialization: Surgical procedure that creates a permanent opening of the duct into the vestibule; used for recurrent cysts in younger patients.
  • Excision of the Bartholin gland: Considered for recurrent cysts/abscesses or when malignancy is a concern (especially over age 40). Excision requires operative settings and careful hemostasis.
  • Antibiotics: Indicated if cellulitis or systemic infection is present; choice guided by local practice and microbiology. (Mayo Clinic, ACOG)

Vaginal wall cysts (Gartner, Skene)

  • Small, asymptomatic cysts: Conservative management and observation.
  • Symptomatic or enlarging cysts: Surgical excision is usually curative and provides tissue for pathology. Skene gland cysts that obstruct the urethra often require drainage or excision. (NIH/MedlinePlus, Mayo Clinic)

Infectious conditions

  • Genital herpes (HSV):
  • Acute outbreaks: Systemic antiviral therapy (e.g., acyclovir, valacyclovir) reduces duration and severity. Prompt treatment is most effective when started early. For frequent recurrences, suppressive therapy can be considered. (NIH/MedlinePlus, Mayo Clinic)
  • Local wound care, analgesics, and avoidance of sexual contact until lesions have healed.
  • Genital warts (HPV):
  • Patient-applied treatments: Podofilox, imiquimod (immune response modifier) in appropriate cases; applicator instructions and duration are specific to medication.
  • Provider-administered treatments: Cryotherapy (liquid nitrogen), trichloroacetic acid (TCA), surgical removal, or laser therapy. Choice depends on lesion size, location, pregnancy status, and provider expertise. (Mayo Clinic)
  • Note: HPV vaccination prevents infection with common wart-causing and cancer-associated HPV types but does not treat existing lesions.
  • Molluscum contagiosum:
  • Often self-limited; options include curettage or topical therapy if removal is desired. (NIH/MedlinePlus)
  • Hidradenitis suppurativa:
  • Management is multimodal and may include topical and systemic antibiotics, intralesional corticosteroids, surgical drainage or excision of sinus tracts, and in moderate-to-severe cases biologic therapy (e.g., adalimumab). Early referral to dermatology/colorectal/gynecologic surgery may be indicated. (Cleveland Clinic)

Benign tumors and soft-tissue masses

  • Lipomas and fibromas: Surgical excision if symptomatic, enlarging, or for definitive diagnosis.
  • Vascular lesions: May require referral to a specialist for embolization, laser, or excision based on size and symptoms.

Malignancies

  • Any suspicious lesion requires biopsy. Treatment for vulvar or vaginal cancer depends on stage and may include wide local excision, radical surgery, radiation therapy, and systemic chemotherapy. Multidisciplinary care with gynecologic oncology is essential. (ACOG, NIH)

Special considerations

  • Age: New vulvar masses in individuals older than 40 should be more aggressively evaluated because of the increased malignancy risk. Excision rather than simple drainage of a Bartholin mass is often recommended in older patients. (ACOG)
  • Pregnancy: Management of infections and symptomatic lesions must balance maternal and fetal safety. Some topical agents and procedures are contraindicated; coordination with obstetric care is advised.
  • Immunosuppression (e.g., HIV): Atypical presentations, larger or more persistent lesions, and more rapid progression can occur; closer monitoring and aggressive treatment may be needed.

Prevention and self-care

  • Routine genital hygiene: Use gentle cleansing; avoid harsh soaps or douching, which can disrupt local flora.
  • Safe sexual practices: Barrier methods reduce transmission of some STIs, though they do not eliminate risk entirely.
  • Vaccination: HPV immunization reduces the risk of HPV-related lesions and certain cancers when given according to guidelines.
  • Smoking cessation: Smoking is associated with poorer outcomes in certain vulvar conditions and higher risk of HPV persistence.
  • Early medical evaluation: Prompt evaluation of new, painful, rapidly growing, or recurrent lesions reduces the risk of complications.

When to seek care

Seek urgent or prompt medical attention if any of the following occur:

  • Significant pain, fever, or signs of systemic infection
  • Rapidly enlarging mass
  • Persistent bleeding, ulceration, or nonhealing lesions
  • New lump in someone older than 40 years
  • New urinary symptoms associated with a periurethral mass
  • Recurrent lesions despite treatment

For routine, nonurgent concerns (small painless lumps or asymptomatic cysts), schedule an appointment with a primary care clinician, gynecologist, or sexual health clinic for evaluation.

Complications

Possible complications depend on the underlying diagnosis:

  • Secondary infection after attempted self-drainage
  • Abscess formation and cellulitis
  • Scarring and deformity after recurrent disease or surgery
  • Persistent pain, dyspareunia, or urinary symptoms with large or recurrent lesions
  • Malignant transformation of some chronic conditions is rare but underscores the need for biopsy of suspicious lesions

Follow-up and prognosis

  • Many benign cysts and small lesions have an excellent prognosis with conservative management or minor procedures.
  • Infections like HSV are chronic viral conditions with episodic recurrences; antiviral therapy improves outcomes but does not cure infection. HPV-related warts often respond to treatment but can recur. (NIH, Mayo Clinic)
  • Malignancies require staging and long-term follow-up; outcomes depend on tumor type and stage at diagnosis. Early detection generally improves prognosis. (ACOG)

Frequently asked questions (brief)

  • Can a vaginal lump be cancer?
  • While most vaginal or vulvar lumps are benign (cysts, warts, benign tumors), any persistent, growing, ulcerated, or bleeding lesion — especially in people over 40 — should be biopsied to exclude malignancy. (ACOG, NIH)
  • Should I try to pop or drain the lump myself?
  • No. Self-drainage increases the risk of infection and can complicate proper medical treatment. See a clinician for evaluation. (Mayo Clinic, Cleveland Clinic)
  • Are lumps in the vaginal area contagious?
  • Some causes are infectious (HSV, HPV, molluscum) and can be transmitted to sexual partners; others (lipoma, Gartner cyst) are not contagious. Appropriate testing and counseling depend on the suspected diagnosis. (NIH, CDC)
  • Will I need surgery?
  • Many lumps can be managed conservatively or with office procedures. Surgery may be recommended for recurrent cysts, symptomatic benign tumors, or to obtain a diagnostic biopsy for suspicious lesions. (ACOG, Mayo Clinic)

Conclusion

Vaginal and vulvar lumps encompass a wide range of conditions from benign cysts and skin lesions to infectious diseases and, rarely, malignancy. Accurate diagnosis requires a careful history, targeted physical examination, and sometimes imaging or biopsy. Most lumps are treatable, and timely evaluation reduces complications. If you discover a new lump, particularly if it is painful, rapidly growing, recurrent, or accompanied by bleeding or systemic symptoms, seek medical care for prompt assessment and treatment.

References and resources

  • American College of Obstetricians and Gynecologists (ACOG) — patient education and practice bulletins on Bartholin gland disorders, vulvar disease, and gynecologic cancers.
  • National Institutes of Health (NIH) / MedlinePlus — information on vaginal cysts, genital herpes, molluscum contagiosum, and other vulvovaginal conditions.
  • Mayo Clinic — patient information on Bartholin cysts, genital warts, and genital herpes.
  • Cleveland Clinic — clinical overviews on Bartholin cysts, hidradenitis suppurativa, and vulvar lesions.

(For patient-specific medical advice, diagnosis, or treatment, consult a licensed healthcare professional.)